Pharmaceuticals

We assist our pharmaceutical clients in identifying and protecting IP assets, performing IP due diligence of acquisition targets, advancing and managing new discoveries, developing legal infrastructure, and expanding and protecting US and other commercial interests.

Our attorneys are involved in strategic counseling and litigation activities assembling and asserting patent rights in Hatch-Waxman litigation.

In addition, we work closely with PBMs on multiple matters including significant ERISA issues.

Noteworthy

• ERISA Team Wins Twice for Caremark in Misclassification, Fiduciary Status

Select News & Events

• ERISA Attorneys Win Twice for Caremark

Publications

• Court Voids US EPA Ban on Use of Third-Party Human Test Data
  Environmental & Chemical Regulatory Update
  June 2003
• Distance Health Service Under the General Agreement on Trade in Services
  July 2, 2002, Journal of Health Law